Journal Club: Management of dyslipidemia for CVD risk reduction
Should we treat patients with a target dose or a target LDL level? How often is it helpful to check lipid levels? For primary and secondary prevention, when should we think about using PCSK9 inhibitors, omega-3 fatty acids, niacin, or fibrates?